Solid Therapeutics ApS
CVR 43007068 · Private limited company (ApS) · Active · Medium risk
Solid Therapeutics ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.9% over the next 12 months, which is 1.3 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -15.4m and a net result of DKK -4.4m.
Bankruptcy risk for Solid Therapeutics ApS
1.3 × the average (1.41%) · higher risk than 82% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 43007068
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (4 years)
- Address
- Ole Maaløes Vej 3
2200 København N - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- LPOG ApS STATSAUTORISEREDE REVISORER
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 4 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -224.4% |
| Current ratio | 1,162% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 167 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -1.7m | DKK -4.2m |
| Net profit | DKK -4.4m | DKK -6.8m |
| Equity | DKK -15.4m | DKK -11.0m |
| Total assets | DKK 6.8m | DKK 11.0m |
| Cash | DKK 5.8m | – |
| Short-term debt | DKK 589k | – |
| Avg. employees | 3 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · LPOG ApS.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 176 | ||
| 1 Jan 2024 – 31 Dec 2024 | 177 | ||
| 1 Jan 2023 – 31 Dec 2023 | 164 | ||
| 21 Jan 2022 – 31 Dec 2022 | 179 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Claus Haase | ||
| CEO | John Sørensen Haurum | ||
| Board | John Sørensen Haurum | Current | |
| Board | Thue Walter Schwartz | Current | |
| Board | Claus Haase | Current | |
| Owner (10%) | John Sørensen Haurum | Current | |
| Owner (20%) | Receptor Holding ApS | Current | |
| Owner (20%) | Frimurer Holdings ApS | Current | |
| Owner (10%) | Haase Invest ApS | Current | |
| Owner (10%) | Stine Helene Falsig Petersen | Current | |
| Owner (20%) | Anne Mette Hyldgaard Trauelsen | Current | |
| Owner (10%) | Hagop Youssoufian | Current | |
| Owner (20%) | Stine Helene Falsig Petersen | ||
| Owner (5%) | Anne Mette Hyldgaard Trauelsen | ||
| Owner (5%) | Hagop Youssoufian | ||
| Auditor | LPOG ApS STATSAUTORISEREDE REVISORER | Current | |
| Founder | John Sørensen Haurum | Current | |
| Founder | Thue Walter Schwartz | Current | |
| Founder | Thomas Michael Frimurer | Current | |
| Founder | Claus Haase | Current | |
| Founder | Stine Helene Falsig Petersen | Current | |
| Founder | Anne Mette Hyldgaard Trauelsen | Current | |
| Founder | Hagop Youssoufian | Current |
The CEOs' other companies
Claus Haase – 1 other companies
- Haase Invest ApS Active
John Sørensen Haurum – 11 other companies
- 3B INVEST ApS Fusioneret
- ARK Invest ApS Active
- Adcendo ApS Active
- COLOTECH A/S Fusioneret
- JSH BIOTECH ApS Active
- KV24 ApS Opløst
- MC2 Therapeutics A/S Active
- Nodus Oncology ApS Opløst
- PROLIFERATOR ApS Opløst
- SANIONA A/S Active
- SYNKLINO A/S Active
Address history (0 moves)
| Ole Maaløes Vej 3, 2200 København N |
Former names
| Solid Therapeutics ApS | – now |
| Warburg Oncology ApS | – |
Other companies at the same address
- 25-06-2019 ApS Bankrupt
- Ankrin Therapeutics ApS Bankrupt
- Avineuro ApS Bankrupt
- BIOREPELLER IVS Bankrupt
- Bainan Biotech ApS Bankrupt
- Broselid Holding IVS Bankrupt
- ChildTreat ApS Bankrupt
- Dencomm ApS Bankrupt
- IO BIOTECH ApS Bankrupt
- Invitreo Biosciences ApS Bankrupt
- Lab Hos Development ApS Bankrupt
- MGM BIO IVS Bankrupt
- Mind the Byte ApS Bankrupt
- PanCryos ApS Bankrupt
- Ressaissi Holding IVS Bankrupt
- SSIP 2023 ApS Bankrupt
- Spit Test Company ApS Bankrupt
- Sterisafe Holding A/S Bankrupt
- Sumondo ApS Bankrupt
- TychoBio IVS Bankrupt
- aiwell Nordic ApS Bankrupt
- 1stBiome ApS Active
- 3Sonic ApS Active
- 55 North General Partner I ApS Active
- 55 North Management ApS Active
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about Solid Therapeutics ApS
Has Solid Therapeutics ApS gone bankrupt?
No, Solid Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Solid Therapeutics ApS?
Our model estimates a bankruptcy risk of 1.9% over the next 12 months (medium risk), which is 1.3 times the average for Danish companies.
Who is the auditor of Solid Therapeutics ApS?
Solid Therapeutics ApS most recently used LPOG ApS STATSAUTORISEREDE REVISORER.
When was Solid Therapeutics ApS founded?
Solid Therapeutics ApS was founded on 21 January 2022.
What is the equity of Solid Therapeutics ApS?
Equity was DKK -15.4m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.